Skip to content
eBook Charts
US
Sequencing with Microarray Technology--a Powerful New Tool for Molecular Diagnostics (Editorial)

Sequencing with Microarray Technology--a Powerful New Tool for Molecular Diagnostics (Editorial)

Clinical Chemistry

$5.99

Buy on Amazon View on Apple Books

Prefer it in print? See every format on Amazon →

Price on Apple Books. Amazon’s price may differ.

Read a lot? Try Kindle+ * · Compare subscriptions

Published
Genres
ChemistryScience & Nature

Description

Nucleic acid sequencing is a fundamental technique that was recognized with the 1980 Nobel Prize in Chemistry. The method allows delineation of DNA sequences with extraordinary accuracy and, since its introduction in the 1970s, has undergone many important modifications and improvements. Among these are the achievement of long reads (up to ~1000 by per analysis), better accuracy (related to the discovery of highly versatile and thermostable sequencing enzymes), improved sensitivity with thermocycling protocols (linear amplifications), full automation, higher speed (related to the introduction of thin gels), and substitution of radioactivity with fluorescent and other probes. All of these improvements have allowed scientists to attempt something that was unthinkable 15-20 years ago, i.e., delineation of the complete sequence of the human genome (~3 x [10.sup.9] bp) and genomes of other organisms. We have already witnessed, over the last few years, the release of the complete sequence of simple organisms as well as of more complex ones, the latest being the Drosophila genome (1). We are now very close to the completion of the entire Human Genome Project (2). These achievements represent a triumph of the DNA sequencing methodology. Now that we (almost) know the complete DNA sequences of these organisms and humans, the question arises. How are we to use this information? The next step will be the complete annotation of the human genome, which will include classification of the raw DNA sequence into well-defined gene structures. We will then need to predict and experimentally verify the encoded proteins and their possible biological functions (physiology). Once this is done, we can begin to ask questions about how genomic variation in certain genes (polymorphisms, mutations) can cause or predispose to specific human diseases (pathophysiology). We already have many examples of subtle genetic changes that can cause very serious human diseases, including cystic fibrosis, various forms of anemias, premature atherosclerosis, cancers, neurodegenerative diseases, autoimmune and immunodeficiency syndromes, and other conditions. The number of known disease-related variations will surely increase dramatically with our increasing knowledge of the sequence of the human genome. Already, many researchers and companies are trying to identify all single nucleotide polymorphisms within the human genome.
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments (Special Report) (Polymerase Chain Reaction) (Report)Clinical Chemistry$5.99A Conversation with Elizabeth Blackburn (Interview)Clinical Chemistry$5.99Two Cases with Unusual Vancomycin Measurements (Clinical Case Study) (Case Study)Clinical Chemistry$5.99Cirrhosis Originally Diagnosed As Nonalcoholic Steatohepatitis (Clinical Case Study)Clinical Chemistry$5.99Low Vitamin D Status in a Representative Sample of Youth from Quebec, Canada (Endocrinology and Metabolism)Clinical Chemistry$5.99Microarray Technology and Applications in the Arena of Genome-Wide Association.Clinical Chemistry$5.99Celiac Disease and IGA Deficiency: Complications of Serological Testing Approaches Encountered in the Clinic (Evidence-Based Laboratory Medicine and Test Utilization) (Clinical Report)Clinical Chemistry$5.99A Girl with Goiter and Inappropriate Thyroid-Stimulating Hormone Secretion (Clinical Case Studies) (Clinical Report)Clinical Chemistry$5.99Why a Cluster is Truly a Cluster: Insulin Resistance and Cardiovascular Disease (Perspective)Clinical Chemistry$5.99Estimating LDL Apob: Infomania Or Clinical Advance?(Editorial) (Clinical Report)Clinical Chemistry$5.99Ghrelin, Leptin, IGF-1, IGFBP-3, and Insulin Concentrations at Birth: Is There a Relationship with Fetal Growth and Neonatal Anthropometry?(Pediatric Clinical Chemistry)Clinical Chemistry$5.99High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial)Clinical Chemistry$5.99